Michael Dennis Price, VP and Chief Financial Officer at NOVEN PHARMACEUTICALS INC (NOVN), bought 15,000 shares at $9.98 ($148K) on 2008-05-12, disclosed to the SEC on 2008-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.78 | 44 | $430 | 0.3% |
| 2 | $9.79 | 1,956 | $19K | 13.0% |
| 3 | $9.80 | 4,500 | $44K | 29.9% |
| 4 | $9.81 | 3,100 | $30K | 20.6% |
| 5 | $9.84 | 100 | $984 | 0.7% |
| 6 | $9.86 | 100 |
| $986 |
| 0.7% |
| 7 | $9.87 | 1,000 | $10K | 6.7% |
| 8 | $9.89 | 894 | $9K | 6.0% |
| 9 | $9.90 | 1,406 | $14K | 9.4% |
| 10 | $9.91 | 100 | $991 | 0.7% |
| 11 | $9.92 | 300 | $3K | 2.0% |
| 12 | $9.98 | 1,500 | $15K | 10.1% |
| Total | $9.84 avg | 15,000 | $148K | 100% |